Unitedhealth Group Inc (UNH) 142.85 $UNH Aetna (AET)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Unitedhealth Group Inc (UNH) 142.85 $UNH

Aetna (AET) Tops Q2 Earnings & Revenues, Guides for 2016
Zacks Equity Research - Zacks Investment Research - 2 hrs 34 mins ago
Aetna's (AET) earnings upside was driven by higher fees and other revenue in Aetna's Health Care segment and lower in general and administrative expenses.
CNC: 68.54 (-0.90), ANTM: 126.14 (-1.47), UNH: 142.85 (-0.66), AET: 115.50 (+1.05)

Developing Telemedicine Market Forecasted to Top $1.2 Billion by 2020 as Innovative Mobile Health Applications Drive Healthcare Sector Forward
PR Newswire Europe - Tue Aug 02, 8:16AM CDT
CORAL SPRINGS, Florida, August 2, 2016 /PRNewswire/ --
CI: 125.18 (-1.61), UNH: 142.85 (-0.66), RHT.VN: 0.135 (-0.025), AET: 115.50 (+1.05), HUM: 169.05 (-2.13)

Cigna (CI) Narrows 2016 Guidance After Q2 Earnings Miss
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 10:18AM CDT
Cigna (CI) missed the estimates due to poor performance from its Global Disability and Life segment.
CNC: 68.54 (-0.90), CI: 125.18 (-1.61), ANTM: 126.14 (-1.47), UNH: 142.85 (-0.66)

Molina's (MOH) Q2 Earnings Beat Estimate: Will Stock Gain?
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 9:50AM CDT
Molina Healthcare Inc. (MOH) reported second-quarter 2016 adjusted net income per share of 67 cents that handily beat the Zacks Consensus Estimate of 52 cents by 29%.
ANTM: 126.14 (-1.47), UNH: 142.85 (-0.66), MOH: 56.75 (+0.59), HUM: 169.05 (-2.13)

Anthem prepping for hardball fight with feds over Cigna deal
By TOM MURPHY - AP - Wed Jul 27, 3:11PM CDT
INDIANAPOLIS (AP) — Anthem has no intention of backing away quietly from its plan to buy rival Cigna in the face of federal opposition, and the company looks ready to play hardball.
CI: 125.18 (-1.61), UNH: 142.85 (-0.66), AET: 115.50 (+1.05), HUM: 169.05 (-2.13)

Anthem (ANTM) Q2 Earnings Beat on Solid Premium Growth
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 9:53AM CDT
Anthem Inc. (ANTM) reported second-quarter 2016 adjusted income of $3.33 per share that beat the Zacks Consensus Estimate of $3.24 by 2.8%.
ANTM: 126.14 (-1.47), UNH: 142.85 (-0.66), AET: 115.50 (+1.05), HUM: 169.05 (-2.13)

UnitedHealth (UNH) Beats on Q2 Earnings: Will Stock Gain?
Zacks Equity Research - Zacks Investment Research - Tue Jul 19, 7:53AM CDT
UnitedHealth Group Inc. (UNH) reported second-quarter 2016 earnings of $1.96 per share, beating the Zacks Consensus Estimate of $1.89. Earnings improved 13% year over year.
UNH: 142.85 (-0.66), WCG: 109.10 (+2.22), SEM: 10.85 (-0.42), AET: 115.50 (+1.05)

UnitedHealth (UNH) Q2 Earnings Beat; Tightens View
Tanuka De - Zacks Investment Research - Tue Jul 19, 6:27AM CDT
UnitedHealth (UNH)beat second quarter earnings by 3.7%. Our consensus called for EPS of $1.89 and the company reported EPS of $1.96.
UNH: 142.85 (-0.66)

UnitedHealth Group Reports Second Quarter Results
BusinessWire - Tue Jul 19, 4:55AM CDT
--UnitedHealthcare Grew Revenues 14% Year-Over-Year,Adding 2.1 Million More People in the Past 12 Months
UNH: 142.85 (-0.66)

4 Blue Chips to Dazzle with Dow Nearly at 20,000
Zacks Equity Research - Zacks Investment Research - Mon Jul 18, 9:22AM CDT
With the Dow all set to hit the 20K mark, investing in solid blue-chip stocks should be a prudent move.
JNJ: 124.67 (-0.73), GE: 31.04 (-0.11), HD: 137.20 (-1.57), GS: 155.85 (-2.33), JPM: 63.51 (-0.29), IBM: 160.84 (-0.61), UNH: 142.85 (-0.66), MCD: 117.58 (-0.43), WMT: 72.72 (-1.06), INTC: 34.43 (-0.42), BA: 131.51 (-1.70), AAPL: 104.13 (-1.92)

Healthcare Q2 Earnings to Watch this Week: UNH, DGX, ADPT
Zacks Equity Research - Zacks Investment Research - Mon Jul 18, 9:01AM CDT
Health insurers are expected to see top-line growth on an increase in member enrollment. Laboratory and diagnostic services is expected to see earnings accretion.
DGX: 85.00 (-1.24), UNH: 142.85 (-0.66), ADPT: 43.36 (-1.43)

Will UnitedHealth (UNH) Continue to Beat on Earnings in Q2?
Zacks Equity Research - Zacks Investment Research - Fri Jul 15, 10:14AM CDT
UnitedHealth (UNH) will report second-quarter results on Jul 19, our proven model does not conclusively show that it will likely beat the Zacks Consensus Estimate.
CNC: 68.54 (-0.90), GILD: 80.01 (-0.45), UNH: 142.85 (-0.66), AFL: 71.24 (-0.34)

UTRGV and United Health Foundation Unveil Mobile Clinic to Deliver Health Care to Rio Grande Valley Communities
BusinessWire - Thu Jul 14, 7:13PM CDT
--Innovative initiative to increase health care access and health education in the Rio Grande Valley is funded through a nearly $3 million grant from United Health Foundation
UNH: 142.85 (-0.66)

Stock Market News for July 07, 2016
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 9:10AM CDT
Benchmarks ended in the green on Wednesday after the FOMC minutes from June meeting showed that most of the Fed policymakers were in favor of keeping rates unchanged.
MDVN: 62.88 (-1.20), BIIB: 298.69 (-3.14), VRTX: 96.53 (-1.67), GILD: 80.01 (-0.45), UNH: 142.85 (-0.66), MRK: 58.39 (-0.27), ALXN: 131.42 (-2.08), XOM: 85.70 (-0.16), CVX: 98.30 (-0.81), REGN: 428.23 (-5.77), CELG: 113.31 (-1.38)


Health insurer's limit on insulin pumps worries patients
By TOM MURPHY - AP - Fri Jun 24, 10:18AM CDT
Stephanie Rodenberg-Lewis wasn't happy with her insulin pump and finally switched two years ago to another brand. Now her health insurer is pushing her to go back.
PODD: 35.06 (-0.32), UNH: 142.85 (-0.66), AET: 115.50 (+1.05)

DeKalb Physician Hospital Organization and UnitedHealthcare to Improve Patients' Care in Georgia
BusinessWire - Thu Jun 23, 11:40AM CDT
--Innovative physician-directed network focused on collaborative care delivery
UNH: 142.85 (-0.66)

Zacks Industry Outlook Highlights: Anthem, Cigna, Aetna, Humana and UnitedHealth Group
Zacks Equity Research - Zacks Investment Research - Thu Jun 23, 8:30AM CDT
Zacks Industry Outlook Highlights: Anthem, Cigna, Aetna, Humana and UnitedHealth Group
CI: 125.18 (-1.61), ANTM: 126.14 (-1.47), UNH: 142.85 (-0.66), AET: 115.50 (+1.05), HUM: 169.05 (-2.13)

Health Insurers Suffer on High Costs, Unprofitable Exchanges
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 3:52PM CDT
Health Insurers Suffer on High Costs, Unprofitable Exchanges
CI: 125.18 (-1.61), ANTM: 126.14 (-1.47), UNH: 142.85 (-0.66), AET: 115.50 (+1.05), HUM: 169.05 (-2.13)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CICYBELL's Black Friday Is a Fashionist's Dream

Updated Category News Views 34

Stepping Into the Fashion Frenzy It’s that time of year again, where shoppers are girding up for Black Friday. And here comes CICYBELL, ready to dish up some meaty discounts that would turn even the most hardened cynic into a frenzied shopper. Alright, maybe that’s a touch dramatic, but let’s break down what this fashion brand is cooking up in their latest sale....

Continue Reading
Horizon Capital Hits €200M for Ukraine Resilience

Updated Category News Views 37

An Unprecedented Leap Amidst Uncertainty Right in the middle of rebuilding a nation, Horizon Capital's Catalyst Fund has managed to tap into a well of optimism—or guts, depending on how you look at it. With €200 million already in its pocket out of a €300 million goal, this private equity powerhouse is taking a calculated gamble on Ukraine's economic resilience and...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 184

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading
MatterSeek Platform Revolutionizing Materials R&D Worldwide

Updated Category News Views 39

Innovating the R&D Landscape with MatterSeek In the ever-changing realm of materials research and development, Yuyao Technology's latest innovation, MatterSeek, is a game changer. It's a slick launch, folks, redefining how we look at the R&D landscape through its AI-driven abilities. This ain't just another pie-in-the-sky platform; it's an actual workhorse designed to...

Continue Reading
HKEX Unveils New Offshore RMB Bond Index

Updated Category News Views 122

Here's the scoop: Hong Kong Exchanges and Clearing Limited (HKEX) just rolled out something worth eyeing—the HKEX Offshore RMB Bond Index. It's the first of its kind from HKEX, catered to those Dim Sum bonds floating around in the city. With Bloomberg lending a hand on the index smarts, this step is poised to give Hong Kong a leg up in the global financial marathon....

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 280

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Bank Hapoalim's Q3 2026: Steady Growth Amid Challenges

Updated Category News Views 22

Digging Deep into Hapoalim's Recent Results Now ain't this a turn of events? Bank Hapoalim rolls out its numbers for Q3 2026, and while there's no confetti dropping from the ceiling, the numbers are telling their own story. Net profit comes to a solid NIS 2,364 million, but we're looking at a landscape that's not all rose-tinted today. The bank's managed to pull off...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 75

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
Galileo's Robot Dog Takes Charge in Polish Warehouses

Updated Category News Views 111

Robotic Innovation Makes Waves in Europe You ever think you’d see the day when a dog—albeit a robotic one—takes the night shift at a warehouse? Well, here we are. Galileo Robotics has unleashed its C1-W robot dog in Poznan, Poland, and it's more than just a fancy tech gimmick. This thing's got potential, bridging gaps left wide open by human labor shortages and...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 115

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

Luckbox Stock Reaches New Low: Market Movements Explained

Updated Category News Views 326

Luckbox Stock Performance Overview The gaming and esports betting company, Luckbox, is currently navigating a fluctuating market landscape, with its stock price recently dipping to a notable 52-week low of $9.68. This shift is a pronounced departure from the previous year, reflecting ongoing challenges within the industry. As of now, the company's market capitalization...

Continue Reading
Nota AI and Renesas: Revolutionizing Driver Monitoring Technology

Updated Category News Views 153

Collaboration Between Nota AI and Renesas Nota AI, known for its expertise in AI optimization, has announced an exciting partnership with Renesas Electronics Corporation, aiming to advance driver monitoring technology through the optimized Driver Monitoring System (DMS). This collaboration is particularly focused on the new RA8P1 microcontroller unit (MCU), which is...

Continue Reading
Mirum Pharmaceuticals Presents Promising LIVMARLI Data at Conference

Updated Category News Views 107

Mirum Pharmaceuticals showcases LIVMARLI research findings Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) has announced its participation in a significant scientific meeting where it aims to present groundbreaking data on LIVMARLI® (maralixibat) oral solution. This event is hosted by the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition...

Continue Reading
Genmab Stock Faces Challenges, Yet Holds Hope for Recovery

Updated Category News Views 130

Genmab Stock Overview Genmab A/S Sponsored ADR (NASDAQ: GMAB) has recently experienced a turbulent period, with a notable decline of 14.7% in just four weeks. However, this decline has left the stock in an oversold position, igniting hope among investors as analysts anticipate improved earnings results. Understanding Oversold Conditions To assess whether a stock, such as...

Continue Reading
Challenges Ahead for Central Banks Tackling Inflation Variability

Updated Category News Views 117

Challenges Ahead for Central Banks in Addressing Inflation Fluctuations Inflation is a complex issue for policymakers, as recent comments from European Central Bank President Christine Lagarde illustrate. With substantial changes happening in the global economy, the prospect of stable inflation remains uncertain. Lagarde suggests that inflation may experience significant...

Continue Reading